{
    "RADCURE-0848": {
        "question": "Age: 58.6, Sex: Male, ECOG PS: ECOG 1, Smoking PY: 40, Smoking Status: Current, Ds Site: Oropharynx, Subsite: Tonsil, T: T2, N: N2b, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: positive, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 0\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-positive cases. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The bounding box coordinates provided are [[248, 200, 86, 248, 225, 105], [248, 200, 86, 248, 225, 105]], which appear to be identical, indicating a single region of interest (ROI) repeated twice.\n\n2. These coordinates are normalized relative to the original image size, but without the original image dimensions, the exact anatomical location is unclear. However, the z, y, x ranges suggest a relatively small, localized volume.\n\n3. The CT scan is of the head and neck region. The ROI likely corresponds to a specific anatomical structure or lesion within this area.\n\n4. From a radiation oncology perspective, the key is to identify if this ROI corresponds to a tumor volume (gross tumor volume, GTV), involved lymph nodes, or critical organs at risk (OARs) such as the spinal cord, brainstem, parotid glands, or pharyngeal constrictors.\n\n5. Since the ROI is relatively small and localized, it may represent a tumor or involved lymph node.\n\n6. No visible abnormalities or anatomical structures can be definitively described without the actual image or further clinical context.\n\n7. Without additional clinical data (tumor stage, HPV status, treatment plan), survival probability cannot be precisely estimated.\n\nFinal answer:\n\nAnswer: Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: no\nReason: Sufficient expertise within scope\n---",
        "Round 2-role-comment": "radiation oncologist:alive",
        "Round 2-num_agents": 1,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}